Caliway Biopharmaceuticals Co., Ltd.

TWSE:6919 Stock Report

Market Cap: NT$75.0b

Caliway Biopharmaceuticals Dividends and Buybacks

Dividend criteria checks 0/6

Caliway Biopharmaceuticals does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-12.7%

Buyback Yield

Total Shareholder Yield-12.7%
Future Dividend Yield1.1%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Companies Like Caliway Biopharmaceuticals (TWSE:6919) Can Afford To Invest In Growth

Oct 02
Companies Like Caliway Biopharmaceuticals (TWSE:6919) Can Afford To Invest In Growth

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 6919's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 6919's dividend payments have been increasing.


Dividend Yield vs Market

Caliway Biopharmaceuticals Dividend Yield vs Market
How does 6919 dividend yield compare to the market?
SegmentDividend Yield
Company (6919)n/a
Market Bottom 25% (TW)1.7%
Market Top 25% (TW)4.5%
Industry Average (Pharmaceuticals)2.2%
Analyst forecast (6919) (up to 3 years)1.1%

Notable Dividend: Unable to evaluate 6919's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 6919's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate 6919's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 6919 has not reported any payouts.


Discover strong dividend paying companies